Correction to: Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays

AAPS J. 2020 Feb 4;22(2):42. doi: 10.1208/s12248-020-0425-8.

Authors

Boris Gorovits¹, Michele Fiscella², Mike Havert³, Eugen Koren⁴, Brian Long⁵, Mark Milton⁶, Shobha Purushothama⁷

Affiliations

¹ Pfizer Inc., Andover, MA, USA. Boris.Gorovits@pfizer.com.
² REGENXBIO Inc., Rockville, MD, USA.
³ bluebird bio, Cambridge, MA, USA.
⁴ Precision for Medicine, Inc., Costa Mesa, CA, USA.
⁵ BioMarin Pharmaceutical Inc, Novato, CA, USA.
⁶ Novartis Institutes for BioMedical Research, Inc., Cambridge, MA, USA.
⁷ Alzheimer's Drug Discovery Foundation, New York, NY, USA.

PMID: 32020345
DOI: 10.1208/s12248-020-0425-8

Abstract

The first author's name was published incorrectly as "Gorovits Boris". The correct name is "Boris Gorovits".

Publication types

Published Erratum